Pharmacokinetic (PK) Evaluation of Bemotrizinol (6%) in a Sunscreen Maximum Usage Trial

NCT05277376 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

162

Enrollment

INDUSTRY

Sponsor class

Conditions

Pharmacokinetics
Absorption; Chemicals

Interventions

DRUG: Bemotrizinol (6%)

Sponsor

dsm-firmenich Switzerland AG